
Repare Therapeutics RPTX
€ 1.54
-4.28%
Quartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Repare Therapeutics Langfristiger Schuldenstrom 2011-2025 | RPTX
Langfristiger Schuldenstrom Jährlich Repare Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.84 M | 2.4 M | 2.17 M | 1.72 M | 697 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.4 M | 697 K | 1.77 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
428 K | $ 11.3 | -10.17 % | $ 12.2 K | - | |
|
Galera Therapeutics
GRTX
|
133 K | $ 0.14 | -32.59 % | $ 7.61 M | ||
|
Axon Enterprise
AXON
|
9.45 M | $ 755.0 | 0.8 % | $ 57.2 B | ||
|
Caladrius Biosciences
CLBS
|
137 K | $ 0.43 | -16.75 % | $ 25.8 M | ||
|
Sorrento Therapeutics
SRNE
|
11.5 M | $ 0.27 | -29.58 % | $ 126 M | ||
|
BeiGene, Ltd.
BGNE
|
17.6 M | $ 184.71 | 0.49 % | $ 251 B | ||
|
Kamada Ltd.
KMDA
|
1.63 M | $ 6.95 | -1.56 % | $ 260 M | ||
|
ContraFect Corporation
CFRX
|
671 K | $ 1.47 | -5.16 % | $ 5.39 M | ||
|
Orchard Therapeutics plc
ORTX
|
6.42 M | $ 4.93 | 1.02 % | $ 90.8 M | ||
|
Advaxis
ADXS
|
166 K | $ 0.31 | -9.65 % | $ 45.9 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
154 K | $ 6.2 | - | $ 154 M | ||
|
Zymeworks
ZYME
|
1.31 M | $ 6.42 | - | $ 404 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | $ 5.72 | 5.93 % | $ 314 M | ||
|
Mesoblast Limited
MESO
|
3.19 M | $ 16.73 | 0.12 % | $ 10.9 B | ||
|
Zosano Pharma Corporation
ZSAN
|
1.61 M | $ 0.56 | 7.23 % | $ 2.72 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | $ 0.5 | - | $ 7.46 M | ||
|
Kiromic BioPharma
KRBP
|
685 K | $ 3.15 | 6.61 % | $ 3.08 M | ||
|
Moderna
MRNA
|
14 M | $ 25.35 | -4.91 % | $ 9.73 B | ||
|
Albireo Pharma
ALBO
|
3.08 M | $ 44.15 | -0.23 % | $ 916 M | ||
|
Merus N.V.
MRUS
|
1.7 M | $ 94.9 | 0.32 % | $ 6.09 B | ||
|
Stealth BioTherapeutics Corp
MITO
|
9 M | $ 0.32 | - | $ 23.9 M | ||
|
Kaleido Biosciences
KLDO
|
2.63 M | $ 0.29 | -3.69 % | $ 12.4 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
704 K | $ 2.19 | - | $ 105 M | ||
|
Aptinyx
APTX
|
337 K | $ 0.06 | -39.0 % | $ 4.57 M | ||
|
Tyme Technologies
TYME
|
34.7 K | $ 0.31 | 8.07 % | $ 54 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | $ 0.39 | - | $ 26.5 M | ||
|
Celyad Oncology SA
CYAD
|
137 K | $ 0.47 | - | $ 12.5 M | ||
|
Nektar Therapeutics
NKTR
|
19.3 M | $ 60.92 | -2.64 % | $ 11.6 B | ||
|
Brickell Biotech
BBI
|
49 K | $ 2.11 | -5.38 % | $ 6.06 M | ||
|
Genocea Biosciences
GNCA
|
2.35 M | $ 0.05 | -15.0 % | $ 3.04 M | ||
|
Codiak BioSciences
CDAK
|
2.66 M | $ 0.06 | -55.98 % | $ 2.15 M | ||
|
Concert Pharmaceuticals
CNCE
|
1.16 M | $ 8.37 | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
410 K | $ 3.17 | 1.93 % | $ 17.4 M | ||
|
Calithera Biosciences
CALA
|
1.37 M | $ 0.37 | -10.95 % | $ 876 K | ||
|
Ocular Therapeutix
OCUL
|
1.93 M | $ 11.53 | -0.17 % | $ 1.82 B | ||
|
Forma Therapeutics Holdings
FMTX
|
5.12 M | $ 20.01 | - | $ 958 M | ||
|
Oragenics
OGEN
|
9.81 K | $ 1.29 | -2.27 % | $ 2.9 M | ||
|
Oncolytics Biotech
ONCY
|
277 K | $ 1.22 | 0.83 % | $ 115 M |